Silicone gel from breast implants produced by Poly Implant Prothèse (PIP) is the subject of a recent opinion from the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). Tests for genotoxicity and cytotoxicity indicated no adverse outcomes for these endpoints, but an in vivo test for irritancy indicated a potential for local effects if the gel is released from the implant (e.g. through implant rupture). SCENIHR concludes that there is insufficient evidence to support the idea that PIP silicone breast implants pose a greater health risk to women than other breast implants, and proposes that further work be done to establish with greater certainty the health risks, if any, that may be associated with breast implants containing this type of silicone gel.

European Commission (2012). The safety of PIP silicone breast implants. SCENIHR adopted this opinion by written procedure on 1st February 2012.

http://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_034.pdf

The above item was taken from the March 2012 issue of Toxicology and Regulatory News which is sent automatically to members of bibra (click here for more details).

News Home Guest Write For Us? Contact Us